Session » Plenary III (1424–1429)
- 10:30AM-10:45AM
-
Abstract Number: 1424
Secukinumab Treatment in Children and Adolescents with Enthesitis-related Arthritis and Juvenile Psoriatic Arthritis: Efficacy and Safety Results from a Phase 3 Study
- 10:45AM-11:00AM
-
Abstract Number: 1425
Voclosporin for Lupus Nephritis: Interim Analysis of the AURORA 2 Extension Study
- 11:00AM-11:15AM
-
Abstract Number: 1426
Genotype and Transfusion Dependence Predicts Mortality in VEXAS Syndrome, a Newly Described Disease with Overlap Inflammatory and Hematologic Features
- 11:15AM-11:30AM
-
Abstract Number: 1427
Reduction of Cardiovascular Disease and Mortality versus Risk of New Onset Diabetes with Statin Use in Patients with Rheumatoid Arthritis
- 11:30AM-11:45AM
-
Abstract Number: 1428
Association Between Ongoing Glucocorticoid Use and Major Adverse Cardiovascular Events Among Veterans with Rheumatoid Arthritis